Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
<p>Abstract</p> <p>Background</p> <p>Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate vaccine. A mixture of influenza...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2008-10-01
|
| Seri Bilgileri: | Virology Journal |
| Online Erişim: | http://www.virologyj.com/content/5/1/131 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|